Plasmid DNA Contract Manufacturing Market, By Plasmid Size and Complexity (Small Plasmids, Large Plasmids and Complex Plasmids (e.g., viral vectors)), By Service Type, By Therapeutic Area, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Plasmid DNA Contract Manufacturing Market size was valued at USD 381.54 Million in 2023, expanding at a CAGR of 19.43% from 2024 to 2032.
The Plasmid DNA Contract Manufacturing Market involves the outsourcing of production processes related to plasmid DNA, which is widely used in biotechnology and pharmaceutical research. The rising demand for gene therapy and vaccine development boosted the growth of contract manufacturing services for plasmid DNA. However, restraints such as regulatory challenges and the complexity of manufacturing processes pose hurdles to market expansion. Opportunities lie in the rising investments in biotechnology and the development of novel therapies, which create a conducive environment for contract manufacturers to capitalize on the growing demand for plasmid DNA.
Plasmid DNA Contract Manufacturing Market- Market Dynamics
Ø The increasing demand for plasmid (pDNA) DNA and increasing research and development activities by key players in the market
The demand for plasmid DNA is witnessing a notable upsurge, driven by increasing research and development activities undertaken by prominent market players. This trend is indicative of the growing importance of plasmid DNA in various biotechnological applications, including gene therapy, vaccine development, and genetic engineering. Furthermore, contract manufacturing organizations are contributing to the expansion of the plasmid DNA market. These efforts are aimed at addressing unmet medical needs and driving innovation in the biotechnology sector.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PLASMID DNA CONTRACT MANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Ø Aldevron, LLC
Ø Catalent, Inc.
Ø Cell and Gene Therapy Catapult (CGT Catapult)
Ø Cobra Biologics (a subsidiary of Cognate BioServices)
Ø Codex DNA, Inc.
Ø Eurofins Scientific
Ø Fujifilm Diosynth Biotechnologies
Ø Kaneka Corporation
Ø Lonza Group Ltd.
Ø MilliporeSigma (a business of Merck KGaA)
Ø PlasmidFactory GmbH & Co. KG
Ø Sirion Biotech GmbH
Ø Thermo Fisher Scientific Inc.
Ø VGXI, Inc. (a subsidiary of GeneOne Life Science Inc.)
Ø Wuxi Biologics
Ø Others
GLOBAL PLASMID DNA CONTRACT MANUFACTURING MARKET, BY PLASMID SIZE AND COMPLEXITY- MARKET ANALYSIS, 2019 - 2032
Ø Small Plasmids
Ø Large Plasmids
Ø Complex Plasmids (e.g., viral vectors)
GLOBAL PLASMID DNA CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032
Ø Plasmid DNA Manufacturing
Ø Process Development and Optimization
Ø Analytical Testing and Quality Control
Ø Formulation and Fill-Finish Services
Ø Others
GLOBAL PLASMID DNA CONTRACT MANUFACTURING MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032
Ø Oncology
Ø Genetic Disorders
Ø Infectious Diseases
Ø Rare Diseases
Ø Autoimmune Disorders
Ø Others
GLOBAL PLASMID DNA CONTRACT MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Ø Gene Therapy
Ø Vaccines
Ø Cell Therapy
Ø Protein Production
Ø Research and Development
Ø Others
GLOBAL PLASMID DNA CONTRACT MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
Ø North America
o The U.S.
o Canada
Ø Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Ø Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Ø Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
Ø The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Plasmid DNA Contract Manufacturing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Plasmid DNA Contract Manufacturing Market Snippet by Plasmid Size and Complexity
2.1.2. Plasmid DNA Contract Manufacturing Market Snippet by Service Type
2.1.3. Plasmid DNA Contract Manufacturing Market Snippet by Therapeutic Area
2.1.4. Plasmid DNA Contract Manufacturing Market Snippet by Application
2.1.5. Plasmid DNA Contract Manufacturing Market Snippet by Country
2.1.6. Plasmid DNA Contract Manufacturing Market Snippet by Region
2.2. Competitive Insights
3. Plasmid DNA Contract Manufacturing Key Market Trends
3.1. Plasmid DNA Contract Manufacturing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Plasmid DNA Contract Manufacturing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Plasmid DNA Contract Manufacturing Market Opportunities
3.4. Plasmid DNA Contract Manufacturing Market Future Trends
4. Plasmid DNA Contract Manufacturing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Plasmid DNA Contract Manufacturing Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Plasmid DNA Contract Manufacturing Market Landscape
6.1. Plasmid DNA Contract Manufacturing Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Plasmid DNA Contract Manufacturing Market – By Plasmid Size and Complexity
7.1. Overview
7.1.1. Segment Share Analysis, By Plasmid Size and Complexity, 2023 & 2032 (%)
7.1.2. Small Plasmids
7.1.3. Large Plasmids
7.1.4. Complex Plasmids (e.g., viral vectors)
8. Plasmid DNA Contract Manufacturing Market – By Service Type
8.1. Overview
8.1.1. Segment Share Analysis, By Service Type, 2023 & 2032 (%)
8.1.2. Plasmid DNA Manufacturing
8.1.3. Process Development and Optimization
8.1.4. Analytical Testing and Quality Control
8.1.5. Formulation and Fill-Finish Services
8.1.6. Others
9. Plasmid DNA Contract Manufacturing Market – By Therapeutic Area
9.1. Overview
9.1.1. Segment Share Analysis, By Therapeutic Area, 2023 & 2032 (%)
9.1.2. Oncology
9.1.3. Genetic Disorders
9.1.4. Infectious Diseases
9.1.5. Rare Diseases
9.1.6. Autoimmune Disorders
9.1.7. Others
10. Plasmid DNA Contract Manufacturing Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Service Type, 2023 & 2032 (%)
10.1.2. Gene Therapy
10.1.3. Vaccines
10.1.4. Cell Therapy
10.1.5. Protein Production
10.1.6. Research and Development
10.1.7. Others
11. Plasmid DNA Contract Manufacturing Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Plasmid DNA Contract Manufacturing Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Plasmid DNA Contract Manufacturing Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Plasmid DNA Contract Manufacturing Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.8.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Plasmid DNA Contract Manufacturing Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Plasmid DNA Contract Manufacturing Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Plasmid DNA Contract Manufacturing Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Aldevron, LLC
12.2.2. Catalent, Inc.
12.2.3. Cell and Gene Therapy Catapult (CGT Catapult)
12.2.4. Cobra Biologics (a subsidiary of Cognate BioServices)
12.2.5. Codex DNA, Inc.
12.2.6. Eurofins Scientific
12.2.7. Fujifilm Diosynth Biotechnologies
12.2.8. Kaneka Corporation
12.2.9. Lonza Group Ltd.
12.2.10. MilliporeSigma (a business of Merck KGaA)
12.2.11. PlasmidFactory GmbH & Co. KG
12.2.12. Sirion Biotech GmbH
12.2.13. Thermo Fisher Scientific Inc.
12.2.14. VGXI, Inc. (a subsidiary of GeneOne Life Science Inc.)
12.2.15. Wuxi Biologics
12.2.16. Others
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
